Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
 
  
   
Insider Information:   Pops Richard F
Relationship:   Director
City:   Cambridge
State:   MA
   
Insider Summary:
  
   
Companies Owned :   4    
Direct Shares   1,301,687    

Indirect Shares

  0      
Direct Value   $38,585,989    

Indirect Value

  $0      
Total Shares   1,301,687      
Total Value   $38,585,989      


Neurocrine Biosciences Inc
 $4,199,262 Alkermes Plc
 $28,489,151 Epizyme, Inc.
 $88,200 Acceleron Pharma Inc
 $5,809,375 Neurocrine Biosciences Inc
 $4,199,262 Alkermes Plc
 $28,489,151 Epizyme, Inc.
 $88,200 Acceleron Pharma Inc
 $5,809,375
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :

    0   
    0    

     Stock price went up :

    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Neurocrine Biosciences Inc NBIX Director 2024-03-13 29,512 2005-11-23 0    Premium*  
            Alkermes Plc ALKS Director and CEO, Alke... 2024-02-08 1,179,675 2011-09-16 0    Premium*  
            Epizyme, Inc. EPZM Director 2013-05-30 60,000 0    Premium*  
            Acceleron Pharma Inc XLRN Director 2019-01-25 32,500 0    Premium*  
* Premium Members only  

Records found :    257         Free Registration Required For Full Results.    Limit: 25

Download
  Page 5 of 11
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

 
3m +/-  
Form
ALKS Alkermes Plc Director and CEO, Alkermes plc   •       •      –    2019-03-13 4 OE $8.55 $135,338 D/D 15,829 732,262 0 -
ALKS Alkermes Plc Director and CEO, Alkermes plc   •       •      –    2019-03-13 4 AS $33.51 $530,485 D/D (15,829) 716,433 0 -
ALKS Alkermes Plc Director and CEO, Alkermes plc   •       •      –    2013-02-25 4 AS $20.72 $336,655 D/D (16,250) 421,047 0 -
ALKS Alkermes Plc Director and CEO, Alkermes plc   •       •      –    2013-02-25 4 OE $9.97 $162,013 D/D 16,250 437,297 0 -
ALKS Alkermes Plc Director and CEO, Alkermes plc   •       •      –    2017-03-01 4 OE $0.00 $0 D/D 17,500 631,757 0 -
ALKS Alkermes Plc Director and CEO, Alkermes plc   •       •      –    2018-03-01 4 OE $0.00 $0 D/D 17,500 666,910 0 -
ALKS Alkermes Plc Director and CEO, Alkermes plc   •       •      –    2019-03-01 4 OE $0.00 $0 D/D 17,500 724,203 0 -
ALKS Alkermes Plc Director and CEO, Alkermes plc   •       •      –    2020-03-01 4 OE $0.00 $0 D/D 17,500 766,864 0 -
ALKS Alkermes Plc Director and CEO, Alkermes plc   •       •      –    2019-02-16 4 OE $0.00 $0 D/D 18,125 699,753 0 -
ALKS Alkermes Plc Director and CEO, Alkermes plc   •       •      –    2020-02-16 4 OE $0.00 $0 D/D 18,125 734,558 0 -
ALKS Alkermes Plc Director and CEO, Alkermes plc   •       •      –    2021-02-16 4 OE $0.00 $0 D/D 18,125 777,219 0 -
ALKS Alkermes Plc Director and CEO, Alkermes plc   •       •      –    2022-02-16 4 OE $0.00 $0 D/D 18,125 855,580 0 -
ALKS Alkermes Plc Director and CEO, Alkermes plc   •       •      –    2016-04-19 4 AS $40.15 $752,863 D/D (18,750) 576,497 0 -
ALKS Alkermes Plc Director and CEO, Alkermes plc   •       •      –    2016-04-19 4 OE $20.79 $389,813 D/D 18,750 595,247 0 -
NBIX Neurocrine Biosciences In... Director   –       •      –    2005-11-23 4 OE $5.25 $130,000 D/D 20,000 20,000 -
NBIX Neurocrine Biosciences In... Director   –       •      –    2005-11-23 4 S $61.55 $1,242,011 D/D (20,000) 0 -
ALKS Alkermes Plc Director and CEO, Alkermes plc   •       •      –    2015-10-05 4 A $0.00 $0 D/D 20,000 562,917 0 -
ALKS Alkermes Plc Director and CEO, Alkermes plc   •       •      –    2016-10-05 4 OE $0.00 $0 D/D 20,000 618,372 0 -
ALKS Alkermes Plc Director and CEO, Alkermes plc   •       •      –    2018-05-22 4 OE $12.29 $245,800 D/D 20,000 686,352 0 -
ALKS Alkermes Plc Director and CEO, Alkermes plc   •       •      –    2018-05-22 4 AS $45.33 $909,163 D/D (20,000) 666,352 0 -
NBIX Neurocrine Biosciences In... Director   –       •      –    2024-03-13 4 AS $140.33 $3,255,621 D/D (23,200) 29,512 0 %
NBIX Neurocrine Biosciences In... Director   –       •      –    2024-03-13 4 OE $42.76 $992,032 D/D 23,200 52,712 0 -
ALKS Alkermes Plc Director and CEO, Alkermes plc   •       •      –    2016-03-15 4 AS $31.40 $784,910 D/D (25,000) 576,497 0 -
ALKS Alkermes Plc Director and CEO, Alkermes plc   •       •      –    2016-03-15 4 OE $20.79 $519,750 D/D 25,000 601,497 0 -
ALKS Alkermes Plc Director and CEO, Alkermes plc   •       •      –    2016-03-22 4 OE $20.79 $519,750 D/D 25,000 601,497 0 -

  257  Records found
  1   2   3   4   5  6   7   8   9   10   11      
  Page 5 of 11  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed